Atlas Trials

Deep Learning Model to Predict the Recurrence of Stage IA Invasive Lung Adenocarcinoma After Sub-lobar Resection

Clinical trial NCT06659601 · COMPLETED

Trial details

NCT number
NCT06659601
Sponsor
First Affiliated Hospital of Chongqing Medical University
Status
COMPLETED
Study type
OBSERVATIONAL
Focus on Developing a Deep Learning Model to Predict the Recurrence Risk of Stage IA Invasive Lung Adenocarcinoma After Sub-lobar Resection
Start date
2023-06-01
Primary completion
2024-01-01
Enrollment
9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.